⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 17, 2024ESC Heart FailureOpen Access

Prognostic impact of beta‐blocker use by N‐terminal pro‐brain natriuretic peptide level in acute heart failure patients

Shin‐Jae Kim Soe Hee Ann Gyung‐Min Park Yong‐Giun Kim Sangwoo Park Sang‐Gon Lee

View Full Paper

Ask AI

Bookmark

Share

Abstract

Both patients with heart failure (HF) with reduced ejection fraction (HFrEF) and those with HF with preserved ejection fraction (HFpEF) present with elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) and have multiple comorbidities; consequently, the prognostic effect of NT-proBNP according to beta-blocker (BB) use is unknown.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kim et al. (2024) studied this question.

synapsesocial.com/papers/68e60015b6db643587593b20 https://doi.org/10.1002/ehf2.14974

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prevalence and Prognosis of Heart Failure with Preserved Ejection Fraction and Elevated N-Terminal Pro Brain Natriuretic Peptide: A 10-year Analysis from the Copenhagen Hospital Heart Failure StudyPrognostic Study · 2012 · 42 citations
2Prognostic Importance of Plasma NT-Pro BNP in Chronic Heart Failure in Patients Treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) Trialcohort · 2007 · 80 citations
3Does NT‐proBNP Remain a Sensitive Biomarker for Chronic Heart Failure after Administration of a Beta‐blocker?RCT · 2007 · 5 citations
4Prognostic value of N-terminal Brain Natriuretic Peptide (NT-proBNP) in Risk Assessment of Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Heart Failure with Reduced Left Ventricular Systolic Functioncohort · 2023
5Relationship between Plasma Concentrations of N-Terminal Pro Brain Natriuretic Peptide and the Characteristics and Outcome of Patients with a Clinical Diagnosis of Diastolic Heart Failure: A Report from the PEP-CHF Studycohort · 2012 · 69 citations

More related papers

Predictive value of NT pro BNP for new‐onset atrial fibrillation in heart failure and preserved ejection fraction2024
N-Terminal pro-brain natriuretic peptide as a diagnostic and prognostic marker in patients with heart failure2022
Assessment of B-type natriuretic peptide (BNP) and n-terminal (NT)-probnp in hypertensive patients with heart failure2004

More from ESC Heart Failure

Multimodal Atrial Cardiomyopathy Phenotypes for Risk Stratification in Severe Aortic Stenosis Undergoing TAVIMon,
Finerenone versus Steroidal MRAs in Type 2 Diabetes and Chronic Kidney Disease without Prior Heart FailureMon,